News

Filter

Current filters:

Kuvan

1 to 9 of 10 results

Extended US market exclusivity for BioMarin's rare disease drug Kuvan

14-04-2014

US drugmaker BioMarin Pharmaceutical says that the Food and Drug Administration has granted Kuvan (sapropterin…

BioMarin PharmaceuticalKuvanNorth AmericaPharmaceuticalRare diseasesRegulationUSA

Merck Serono launches Kuvan in Europe

23-04-2009

Merck Serono, a division of Germany's Merck KGaA, has launched Kuvan (sapropterin dihydrochloride) in…

KuvanMerck KGaASaproterin Dihydrochloride Tablets

Merck Serono

15-12-2008

German drugmaker Merck Serono's Kuvan (sapropterin dihydrochloride) has been approved in Europe for the…

KuvanMerck KGaASaproterin Dihydrochloride Tablets

FDA clears orphan drug Kuvan for PKU

14-01-2008

The US Food and Drug Administration has approved Kuvan (sapropterin diHCl), an orphan drug and the first…

Daiichi SankyoKuvanMerck KGaASankyoSaproterin Dihydrochloride Tablets

BioMarin grants exclusive data on Kuvan to Asubio

24-09-2007

California, USA-based BioMarin Pharmaceutical has licensed to Asubio Pharma, a subsidiary of Daiichi…

Daiichi SankyoKuvanMerck KGaANystatinOralSankyoSaproterin Dihydrochloride Tablets

Strong Ph III study data for BioMarin's PKU drug

20-08-2007

The USA's BioMarin Pharmaceutical has reported positive final results from a Phase III trial of Kuvan…

KuvanMerck KGaANystatinOralSaproterin Dihydrochloride Tablets

1 to 9 of 10 results

COMPANY SPOTLIGHT

Menarini

Back to top